Detecting heart stiffness with pacemaker data
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study tests if a pacemaker or defibrillator can spot a rare heart condition called cardiac amyloidosis by measuring electrical signals in the right ventricle. It might help people with thickened heart walls find out sooner if they have this treatable disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older
- You need a pacemaker or defibrillator with pacing because of a slow or blocked heartbeat
- An ultrasound shows your heart's main pumping chamber wall is thickened (12mm or more)
- You do not have severe aortic valve narrowing
- You have not been diagnosed with cardiac amyloidosis before
- You are covered by French social security or equivalent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if setting a pacemaker to a faster heart rate (70 beats per minute) can help people with a specific type of heart disease called ATTR cardiac amyloidosis. It is for people who already have a pacemaker and have heart failure symptoms.
This study uses advanced heart scans and AI technology to find early signs of amyloidosis (a protein buildup in the heart) in people with atrial fibrillation. Catching it early may help prevent serious heart problems.
This trial aims to better diagnose cardiac amyloidosis — a condition where abnormal proteins build up in the heart — by testing whether certain warning signs (called 'red flags') can help identify it. If you have any of these signs, the study will use heart scans to confirm the diagnosis.
This study tests whether pacing your heart at a faster rate helps people with cardiac amyloidosis (a condition where abnormal protein builds up in the heart). If you have a pacemaker and cardiac amyloidosis, this research might help doctors understand the best pacing settings for you.
This study measures how well the heart’s tiny blood vessels work in people with cardiac amyloidosis, using special heart testing. It may help doctors understand the disease better and improve how patients are evaluated over time.
This study tests whether taking a small tissue sample from the right side of the heart during a routine pacemaker or defibrillator procedure can help find a condition called cardiac amyloidosis, which causes stiffening of the heart muscle. It aims to improve early detection in people who already need a cardiac device and may have early signs of the disease.
Hear when a new Cardiac Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.